Get started
Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

No trades
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪519.30 B‬ JPY
Dividend yield (indicated)
2.38%
Price to earnings Ratio (TTM)
17.0
Basic EPS (TTM)
93.0 JPY
Net income (FY)
‪36.25 B‬ JPY
Revenue (FY)
‪300.00 B‬ JPY
Shares float
‪259.73 M‬
Beta (1Y)
0.43

Employees


Employees (FY)
‪3.85 K‬
Change (1Y)
+105 +2.80%
Revenue / Employee (1Y)
‪77.94 M‬ JPY
Net income / Employee (1Y)
‪9.42 M‬ JPY

About Santen Pharmaceutical Co., Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Takeshi Ito
Website
santen.co.jp
Headquarters
Osaka
Founded
1890
Identifiers
2
ISINJP3336000009
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Check out other big names from the same industry as 4536.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


1306
Next Funds TOPIX Exchange Traded Fund
Weight
0.06%
Market value
‪108.69 M‬
USD
1308
Nikko Exchange Traded Index Fund TOPIX
Weight
0.06%
Market value
‪53.42 M‬
USD
1305
iFreeETF TOPIX
Weight
0.06%
Market value
‪48.28 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.01%
Market value
‪23.06 M‬
USD
1348
MAXIS TOPIX ETF
Weight
0.06%
Market value
‪15.96 M‬
USD
SCZ
iShares MSCI EAFE Small-Cap ETF
Weight
0.10%
Market value
‪12.06 M‬
USD
1475
iShares Core TOPIX ETF
Weight
0.06%
Market value
‪8.96 M‬
USD
INTF
iShares International Equity Factor ETF
Weight
0.28%
Market value
‪7.93 M‬
USD
SPDW
SPDR Portfolio Developed World ex-US ETF
Weight
0.02%
Market value
‪5.42 M‬
USD
IJPA
iShares Core MSCI Japan IMI UCITS ETF
Weight
0.06%
Market value
‪4.29 M‬
USD
SJPE
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged Accum
Weight
0.06%
Market value
‪4.29 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of 4536 is 1,647.5 JPY — it has increased by 3.16% in the past 24 hours. Watch Santen Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange Santen Pharmaceutical Co., Ltd. stocks are traded under the ticker 4536.
4536 stock has risen by 2.97% compared to the previous week, the month change is a 3.45% rise, over the last year Santen Pharmaceutical Co., Ltd. has showed a 4.74% increase.
We've gathered analysts' opinions on Santen Pharmaceutical Co., Ltd. future price: according to them, 4536 price has a max estimate of 2,600.00 JPY and a min estimate of 1,700.00 JPY. Watch 4536 chart and read a more detailed Santen Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Santen Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
4536 reached its all-time high on Jan 16, 2020 with the price of 2,234.0 JPY, and its all-time low was 200.0 JPY and was reached on Oct 9, 2002. View more price dynamics on 4536 chart.
See other stocks reaching their highest and lowest prices.
4536 stock is 4.38% volatile and has beta coefficient of 0.43. Track Santen Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Santen Pharmaceutical Co., Ltd. there?
Today Santen Pharmaceutical Co., Ltd. has the market capitalization of ‪487.14 B‬, it has increased by 1.10% over the last week.
Yes, you can track Santen Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Santen Pharmaceutical Co., Ltd. is going to release the next earnings report on Feb 5, 2026. Keep track of upcoming events with our Earnings Calendar.
4536 earnings for the last quarter are 24.44 JPY per share, whereas the estimation was 20.89 JPY resulting in a 16.98% surprise. The estimated earnings for the next quarter are 27.89 JPY per share. See more details about Santen Pharmaceutical Co., Ltd. earnings.
Santen Pharmaceutical Co., Ltd. revenue for the last quarter amounts to ‪69.14 B‬ JPY, despite the estimated figure of ‪69.63 B‬ JPY. In the next quarter, revenue is expected to reach ‪74.96 B‬ JPY.
4536 net income for the last quarter is ‪8.06 B‬ JPY, while the quarter before that showed ‪5.88 B‬ JPY of net income which accounts for 37.16% change. Track more Santen Pharmaceutical Co., Ltd. financial stats to get the full picture.
Santen Pharmaceutical Co., Ltd. dividend yield was 2.54% in 2024, and payout ratio reached 34.62%. The year before the numbers were 2.15% and 45.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 18, 2025, the company has ‪3.85 K‬ employees. See our rating of the largest employees — is Santen Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Santen Pharmaceutical Co., Ltd. EBITDA is ‪60.87 B‬ JPY, and current EBITDA margin is 24.73%. See more stats in Santen Pharmaceutical Co., Ltd. financial statements.
Like other stocks, 4536 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Santen Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Santen Pharmaceutical Co., Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Santen Pharmaceutical Co., Ltd. stock shows the strong buy signal. See more of Santen Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.